Skip to main content

Transforming the understanding
and treatment of mental illnesses.

254th Meeting of the National Advisory Mental Health Council Open Policy Session Agenda

Thursday, September 20, 2018
9:00 a.m. - 12:30 p.m.

Conference Room C/D/E
Neuroscience Center
National Institute of Mental Health
6001 Executive Boulevard
Rockville, Maryland 20852

Time Event
9:00 a.m.

Call to Order

Joshua Gordon, M.D., Ph.D.
Director, NIMH

9:00-10:30 a.m.

NIMH Director's Report

Presenter:

Joshua Gordon, M.D., Ph.D.
Director, NIMH

Discussion

10:30 -10:45 a.m

Break

10:45-11:15 a.m.

RDoC Workgroup Update: Addition of the Sensorimotor Domain

Presenter:

Bruce Cuthbert, Ph.D.  
Director, NIMH Research Domain Criteria (RDoC) Unit

Discussion

11:15 a.m.-12:45 p.m

Concept Clearances

Presenters:

Dianne Rausch, Ph.D.
 Division of AIDS Research
Understanding the Mechanisms of Neuropsychiatric Side Effects and Neurological Toxicities of HIV Anti-Retroviral Therapy (ART)

Christopher Gordon, Ph.D.
Division of AIDS Research
Implementation Research to Inform and Enhance President’s Emergency Plan for AIDS Relief (PEPFAR) Pre-exposure Prophylaxis (PrEP) Delivery

Eve Reider, Ph.D.
Division of Services and Intervention Research
Secondary Data Analysis to Examine Long-Term and Cross-Over Effects of Prevention Interventions

Michael Freed, Ph.D.
Division of Services and Intervention Research
Hybrid Effectiveness-Implementation Clinical Trials to Optimize the Collaborative Care Model for Patients with Opioid Use Disorders and Mental Health Conditions

Alexander Arguello, Ph.D.
Division of Neuroscience and Basic Behavioral Science
Computational Methods for Integrative Analysis of Multi-omic and Single-cell Data to Elucidate Cell Type-specific Gene Regulatory Architecture for Mental Disorders 

Michelle Freund, Ph.D.
Office of Technology Development and Coordination
NIH NeuroBioBank

Shelli Avenevoli, Ph.D.
Office of the Director
Renewal of the Adolescent Brain Cognitive Development (ABCD) Study

Shelli Avenevoli, Ph.D.
Office of the Director
Trans-NIH baby Brain Cognitive Development (bBCD) Study – Measuring the Long-Term Impact of Prenatal Exposure to Opioids and Other Substances

Discussion

12:25 p.m.

Public Comment

12:30 p.m.

Adjourn Open Session